In the annual “Taiwan BIO Awards”, SunWay Biotech passed all the steps from the preliminary review to the final one by its multinational patents and strain-based market planning. SunWay Biotech has stood out from 55 biotechnology industry companies and awarded “Taiwan BIO Awards- Emerging Company of the Year“ in 2020! BIO Asia-Taiwan 2020 International Conference & Exhibition SunWay Biotech company is awarded by President Tsai, Ing-Wen Professor Pan, Tzu-Ming introduced the history of SunWay Biotech company Speech of Professor Pan, Tzu-Ming Professor Pan, Tzu-Ming SunWay Biotech is awarded “Taiwan Bio Awards” in 2020.
[Emergency Notice!!] In Taiwan, there are counterfeit red yeast rice bottled products which have been sold via the internet. The fake bottled product is definitely not the original red yeast rice product of Professor Tzu-Ming Pan (娘家大紅趜). As the material provider and manufactory of original red yeast rice product, SunWay Biotech (SunWay) urges everyone should not only stop buying the fake product but also stop forwarding the information of the fake bottled product. The fake bottled product might do harm to your own health. Both SunWay and authorized reseller shall protect our intellectual properties. Please be assured that we would investigate all leads of the illegal activity and shall take appropriate legal action against the mean and unworthy sellers. The counterfeit/fake product (please see the left one) and original product (right one) are shown in the figure below. Please share this emergency notice and keep supporting the original red yeast rice product. Please purchase the product from the official authorized channels, or call the customer service directly at +886-800066099. If you have any questions, please do not hesitate to contact us on the FB or SunWay’s website. Thank you for your help.
An extract from a fermentation product of Monascus purpureus, a species of fungi, could be useful in regulating blood lipids and treating coronary artery diseases, according to researchers in Taiwan. Read more>
Interview from PharmaBoardRoom: George J. Lee, Ph.D. – Chairman; Tzu-Ming Pan, Ph.D – Vice Chairman and Chief Technology and Science Officer, SunWay Biotech, Taiwan
George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech is now bringing this unique product onto the global stage and are considering developing a pharmaceutical product based on the same compounds.
2016 Taiwan-ASEAN Investment Strategy Partner Forum Held as Part of New Southbound Policy: Connect with ASEAN to Create New Business Opportunities
The Taiwan-ASEAN Investment Strategy Partner Forum, organized by the Ministry of Economic Affairs’s (MOEA) Department of Investment Services, was held at the Taipei International Conference Center today (the 13th).
For the past nearly 20 years, ANKASCIN 568-R has been proven by 120+ publications to be effective in managing blood lipids, blood sugar, blood pressure, and improving symptoms of Alzheimer’s disease through many animal tests conducted by Professor Tzu-Ming Pan from National Taiwan University, Taiwan.
With more than ten years of time-consuming and laborious efforts in manifesting the functions and safety, we proudly announce that our NEW red yeast rice extract (ANKASCIN 568-R) has been approved by the US FDA as an NEW DIETARY INGREDIENT (NDI, report # 855).